{"id":"W2749380187","doi":"10.1056/nejmoa1709118","title":"Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2412,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Daiichi Sankyo Europe; LEO Pharma; Servier; Novo Nordisk; Astellas Pharma; Fresenius Medical Care North America; Eisai; Belvoir Media Group; Ironwood Pharmaceuticals, Incorporated; Agence Nationale de la Recherche; Regado Biosciences; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Massachusetts Medical Society; Regeneron Pharmaceuticals; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; University College London; Bayer HealthCare; Sanofi; GlaxoSmithKline; Amgen; Pfizer; U.S. Department of Veterans Affairs","keywords":"Rivaroxaban; Aspirin; Medicine; Disease; Internal medicine; Cardiology; Intensive care medicine; Atrial fibrillation; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003771242,0.0005448259,0.002638752,0.0004697252,0.0002866138,0.0007499494,0.0004153299,0.001099124,0.003715956],"category_scores_gemma":[0.00352196,0.000288116,0.001232258,0.0005299844,0.000631721,0.0005268418,0.0003038867,0.001076955,0.0005023173],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003349431,"about_ca_system_score_gemma":0.0006647865,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002375728,"about_ca_topic_score_gemma":0.0003739799,"domain_scores_codex":[0.9982126,0.001007413,0.0002303563,0.0002356568,0.0002052614,0.0001087707],"domain_scores_gemma":[0.998782,0.0005651427,0.0003039448,0.00007520113,0.00007092142,0.0002027037],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8468031,0.004503195,0.007267512,0.003476846,0.003450916,0.0001805109,0.0001068475,0.0004730819,0.004883307,0.0005193081,0.00153325,0.1268021],"study_design_scores_gemma":[0.8407476,0.1361427,0.01304211,0.0003337204,0.003252304,0.0002825941,0.00002664118,0.000775602,0.001019684,0.0005752599,0.003782608,0.00001919229],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9148549,0.07778018,0.001149988,0.001195108,0.001019576,0.0008239321,0.000427506,0.00004962806,0.002699101],"genre_scores_gemma":[0.9823862,0.01308185,0.001240321,0.000796898,0.0008427101,0.0007125787,0.0002863344,0.000009123402,0.0006439601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003771242,"threshold_uncertainty_score":0.01994449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08434367790045115,"score_gpt":0.3424579357591593,"score_spread":0.2581142578587081,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}